The serum KL-6 concentration in patients with interstitial lung diseases reflects the overall extent of interstitial lesions and serves as a powerful predictor of acute exacerbations of IPF [27, 28]. The gene discussed is MUC1; the disease is idiopathic pulmonary fibrosis.